Current analyst coverage of DRVN points to a central target in the mid-teens. Aggregating the most recent estimates from S&P Global and MarketBeat, the average analyst price target sits around $14.83 to $15.48, across roughly 13 to 17 analysts, with individual targets spanning from about $10 to $23. Rounded, that places the working central target near $15, roughly 39% above the latest price. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The spread is unusually wide, and it reflects genuine disagreement. Bullish firms have cited Take 5's same-store sales momentum and an undemanding valuation. More cautious analysts — including DRVN watchers at BofA Securities and Goldman Sachs, which hold less constructive or Hold views — point to sales headwinds and a leveraged balance sheet. Notably, BTIG downgraded the stock to Neutral in early November 2026, while UBS and Canaccord Genuity have maintained or raised Buy ratings. The consensus rating has drifted from "Moderate Buy" toward "Hold" as targets were trimmed through 2026.
After a steep November decline, DRVN traded near $10.81, within a 52-week range of roughly $9.80 to $17.30. Reaching $15 would require an advance of about 39%, a substantial move that would reclaim levels last seen several months ago. The path hinges on restoring investor confidence in financial reporting — the company disclosed errors in fixed asset accounting, delayed its third-quarter 10-Q filing and earnings call, and revised its fiscal 2026 outlook on November 3, 2026. Preliminary third-quarter results showed total same-store sales up 2.0% and Take 5 same-store sales up 4.9%, suggesting the underlying business remains intact even as the restatement weighs on the shares.
Several factors could underpin a recovery. The Take 5 quick-oil-change concept continues to post solid same-store sales growth, and DRVN benefits from a broad, capital-light franchise network spanning Meineke, Maaco, CARSTAR and related brands. Management has also signaled discipline on the balance sheet, setting a long-term net leverage target of 2–3x net debt to adjusted EBITDA and authorizing a new $100 million share repurchase program. If the restatement is resolved cleanly and comparable-store momentum persists, a re-rating toward the analyst average is plausible.
The obstacles are significant. A financial restatement and delayed filing erode investor trust and can compress valuation multiples even when operations are steady. DRVN also carries a heavy debt burden, and shareholder litigation has been filed in connection with the disclosure issues. Broader consumer-discretionary demand remains uncertain, and BofA Securities has cautioned about sales headwinds. Until the restated financials are filed and the full scope of the accounting errors is known, the stock could remain under pressure regardless of the underlying business.
The $10.80 area now acts as a near-term floor, with the 52-week low near $9.80 serving as a longer-term support level. On the upside, prior congestion in the $12.50–$13.50 zone represents resistance the stock must clear before the $15 target comes into view. The shares' sharp November drop left them below their long-term moving averages, a structure that typically requires time and positive catalysts to repair.
Analyst price targets generally reflect a roughly 12-month research horizon, though the exact period varies by firm. The most important near-term catalysts are the completion of the restatement and the filing of the delayed 10-Q, the rescheduled third-quarter earnings call, and any updated fiscal 2026 guidance. Investors should also watch Take 5 same-store sales trends, balance-sheet and leverage progress, share repurchase activity, and further analyst target revisions.
For traders tracking names like DRVN, Tickeron's AI Daily Buy/Sell Signals offer a data-driven complement to fundamental research. The system uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. This can help traders spot shifting trends, monitor existing positions, and surface opportunities more efficiently than manual screening. In my view, it provides a useful layer when evaluating names amid uncertainty like the current restatement situation.
The question of whether DRVN can reach $15 comes down to execution and trust. The target, a rounded average of analyst estimates spanning roughly $10 to $23, requires a substantial roughly 39% advance from current levels. Supporting the case are Take 5's growth, a durable franchise network, and improving capital allocation. Working against it are the financial restatement, delayed filings, leverage, and litigation. The wide analyst range underscores genuine uncertainty. A credible resolution of the accounting issues and confirmation of continued same-store sales growth are the clearest signals to watch before any sustained move toward the target.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Aroon Indicator for DRVN entered a downward trend on October 30, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 156 similar instances where the Aroon Indicator formed such a pattern. In 110 of the 156 cases the stock moved lower. This puts the odds of a downward move at 71%.
The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DRVN as a result. In 63 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The Moving Average Convergence Divergence Histogram (MACD) for DRVN turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 34 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.
DRVN moved below its 50-day moving average on November 11, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DRVN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +7.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where DRVN advanced for three days, in 193 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
DRVN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. DRVN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.354) is normal, around the industry mean (1.554). P/E Ratio (11.890) is within average values for comparable stocks, (12.811). Projected Growth (PEG Ratio) (0.926) is also within normal values, averaging (0.695). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.030) is also within normal values, averaging (0.919).
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DRVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AutomotiveAftermarket